The Trump administration has tapped Kodak, the legacy film and photography pioneer to produce pharmaceutical ingredients.
The company will receive a $765 million government loan to launch a new division called Kodak Pharmaceuticals, which will eventually produce as much as 25% of the active ingredients for generic medications in the United States.
The deal helps fulfill a key Trump administration priority to reduce dependence on foreign production of drugs and other crucial products.
Attached is a video with all the details about the rise and fall of Kodak over recent decades and its surprising take off in the middle of the coronavirus crisis.
